From: Understanding the genetic determinant of severity in viral diseases: a case of SARS-Cov-2 infection
Classification | Viruses | Important viral genetic variants and SNPs |
---|---|---|
Virus entry receptor modifying enzyme | Norovirus and rotavirus | |
SARS-CoV-2 | ACE2 variants (Lys26Arg, Ile468Val, Ala627Val, Asn638Ser, Ser692Pro, Asn720Asp, Leu731Ile/Leu731Phe) [35] ACE2 SNPs (rs4646127, rs2158082, rs5936011, rs6629110, rs4830983, rs5936029) [35] | |
Innate signaling response | Influenza virus | |
Herpes simplex virus | ||
Hepatitis C virus | TLR7IVS2-151G, TLR8-129G [36] | |
SARS-CoV-2 | ||
MHC/HLA Class 1 | HIV | |
Dengue virus | HLA-A 0207 and HLA-B 51 [30, 33] | |
SARS-CoV-1 | HLA-B 4601, HLA-B 5401 [32] | |
SARS-CoV-2 | HLA-B 1503 [32] | |
MHC/HLA Class 2 | Hepatitis C virus | HLA-DRB1 0301, DQB1 0301, DRB1 0101, DRB1 0401 [49–56] |
SARS-CoV-2 | HLA-DR [38] |